Stay updated on TATE-PD1 Combo in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.

Latest updates to the TATE-PD1 Combo in Liver Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe NIH banner announcing a website transition and the use of “Super Intelligence” terminology has been removed.SummaryDifference1%

- Check18 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA notice was added announcing NIH website changes and describing the agency’s transition from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check32 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the previous study details. This indicates the NCT03259867 record is currently inaccessible from the site.SummaryDifference19%

Stay in the know with updates to TATE-PD1 Combo in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.